Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies.
第一作者:
Alice,Pievani
第一单位:
USC Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
作者:
医学主题词
抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗体依赖细胞细胞毒性(Antibody-Dependent Cell Cytotoxicity);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);细胞, 培养的(Cells, Cultured);细胞因子诱导杀伤细胞(Cytokine-Induced Killer Cells);流式细胞术(Flow Cytometry);荧光抗体技术(Fluorescent Antibody Technique);人类(Humans);免疫疗法(Immunotherapy);淋巴瘤, B细胞(Lymphoma, B-Cell)
DOI
10.1182/blood-2010-06-290858
PMID
21048157
发布时间
2022-04-08
- 浏览29
Blood
510-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



